by Faces of Epilepsy
Revisiting Valeant Pharma Shares of Valeant Pharmaceuticals International Inc. (VRX, VRX.TO) rose more than 18% to $35.55 Thursday on more than 4 times its 3-month average volume on the New York Stock Exchange and were up nearly 19% to C$35.45 on the Toronto Stock Exchange. Read more on RTT News Tags: valeant pharmaceuticals international, Exchange, [...]
Full Epilepsy post →
by Faces of Epilepsy
US epilepsy drug delay LONDON - GLAXOSMITHKLINE PLC and Valeant Pharmaceuticals International say they may have to wait an extra three months for the US regulatory review of their potential epilepsy treatment ezogabine. The two companies said on Tuesday that the US Food and Drug Administration has extended its target date under the Prescription Drug [...]
Full Epilepsy post →